Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Register today to learn more
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / Improve First Treatment Success
Take control of your cattle’s health, and reduce bovine respiratory disease costs
Bovine respiratory disease (BRD) can be a costly expense for cattle producers, however, it’s an expense that can be avoided. BRD is one of the most common and costly diseases affecting the United States cattle industry. In fact, the U.S. feedlot industry estimates an annual loss as high as $1 billion due to loss of production, increased labor expenses, pharmaceutical costs and death deriving from BRD.1,2 The loss of an animal, decreased average daily gain and cost of treatment quickly can put a dent in a producer’s pocket.
“If cattle are treated more than once, they never get back to that peak performance,” said Shawn Blood, DVM, Beef Strategic Technical Services Team, Zoetis. “The weight loss that animal has due to BRD sickness will stay with them throughout the feeding period.”
BRD refers to any disease of the lower or upper respiratory tracts in cattle and is commonly associated with lung infections, which can cause pneumonia. It’s a complex disease caused by a variety of factors, including: • Host factors (animal age, immunity, genetics, exposure to pathogens) • Environmental factors (crowding, temperature, commingling, transport) • Internal or external parasite infections• Infectious agents:o Viruses, including: bovine parainfluenza virus (PI3), infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea (BVD) virus and bovine coronavirus (BCV) o Pathogens, including: Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis To help reduce losses from BRD, it is important for producers to control BRD before it hits their operation. As a first step, Dr. Blood recommends a broad-spectrum antimicrobial like DRAXXIN® (tulathromycin) Injectable Solution as part of an effective BRD control program.
“Without the ability to do rapid animal-side testing to differentiate which bacterial pathogen is in those animals, we rely on a broader antimicrobial that is effective against all of the four main pathogens,” Dr. Blood said. When selecting an antimicrobial to help manage BRD, it is important to select based on efficacy and sound science. Dr. Blood recently helped complete a retrospective review of 12 studies that examined the BRD first-treatment success following metaphylaxis with DRAXXIN in high-risk stocker and feedlot cattle.
In all 12 studies when DRAXXIN was the metaphylactic antimicrobial, there were higher demonstrated BRD first-treatment success rates when an animal was pulled for treatment. Overall, DRAXXIN delivered up to a 22.4% first-treatment success advantage when compared with other metaphylactic antimicrobials.3-12
“The review included all references found in North American studies,” Dr. Blood said. “It’s tough to find a product that shows the best response in 12 studies like that. If the product works right the first time, there is no need for another treatment, which saves the producer money and is better for the animal.”
An effective metaphylactic product on arrival is just one important part of an overall BRD management program. Dr. Blood encourages producers to work closely with their veterinarian to develop a complete BRD management program.
For more information and to learn more about effective BRD control, visit DRAXXIN.com.
IMPORTANT SAFETY INFORMATION: DRAXXIN has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older. Do not use in animals known to be hypersensitive to the product. See full Prescribing Information at draxxin.com/PI.
Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2015, the company generated annual revenue of $4.8 billion with approximately 9,000 employees. For more information, visit www.zoetisUS.com.
For further information, contact:
Leona Ling FergusonZoetis973email@example.com
Aimee RobinsonBader Rutter262firstname.lastname@example.org
1- Hodgins DC, Shewen PE. Pasteurella and Mannheimia spp. infections. In: Coetzer JAW, Tustin RC, eds. Infectious disease of livestock. 2nd ed. Cape Town, South Africa: Oxford University Press; 2004:1672-1676.
2- Fulton RW, Cook BJ, Step DL, et al. Evaluation of health status of calves and impact on feedlot performance: assessment of retained ownership program for postweaning calves. Can J Vet Res. 2002;66(3):173-80.
3- Rooney KA, Nutsch RG, Skogerboe TL, Weigel DJ, Gajewski K, Kilgore WR. Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease. Vet Ther. 2005;6(2):154-66.
4- Booker CW, Abutarbush SM, Schunicht OC, et al. Evaluation of the efficacy of tulathromycin as a metaphylactic antimicrobial in feedlot calves. Vet Ther. 2007;8(3):183-200.
5- Nickell JS, White BJ, Larson RL, Blasi DA, Renter DG. Comparison of short-term health and performance effects related to prophylactic administration of tulathromycin versus tilmicosin in long-hauled, highly stressed beef stocker calves. Vet Ther. 2008;9(2):147-156.
6- Van Donkersgoed J, Merrill JK, Hendrick S. Comparative efficacy of tilmicosin versus tulathromycin as a metaphylactic antimicrobial in feedlot calves at moderate risk for respiratory disease. Vet Ther. 2008;9(4):291-297.
7 - Tennant TC, Ives SE, Harper LB, Renter DG, Lawrence TE. Comparison of tulathromycin and tilmicosin on the prevalence and severity of bovine respiratory disease in feedlot cattle in association with feedlot performance, carcass characteristics, and economic factors. J Anim Sci. 2014;92(11):5203-5213.
8- Data on file, Study Report No. 11RGDRA01, Zoetis Inc.
9- Merck Animal Health. Canadian commercial feedlot study comparing Zuprevo to Draxxin and Micotil when used on arrival in calves at high risk of developing BRD. Technical Bulletin 99-952120 (report S11414-00-MCRCLI-RM), 2012.
10- Miller TJ. Comparison of gamithromycin, tilmicosin and tulathromycin: metaphylactic treatments in high risk calves for bovine respiratory disease [thesis]. Manhattan: College of Veterinary Medicine, Kansas State University; 2013.
11- Data on file, Study Report No. A131R-US-12-028, Zoetis Inc.
12- Torres S, Thomson DU, Bello NM, Nosky BJ, Reinhardt CD. Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease. Am J Vet Res. 2013;74(6):839-846.
All trademarks are the property of Zoetis Inc., its affiliates and/or its licensors.
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved.